Covestro AG (ADR)
General ticker "COVTY" information:
- Sector: Materials
- Industry: Chemicals - Specialty
- Capitalization: $13.1B (TTM average)
Covestro AG (ADR) does not follow the US Stock Market performance with the rate: -8.3%.
Estimated limits based on current volatility of 0.5%: low 34.01$, high 34.35$
Factors to consider:
- Price in estimated range
- Earnings for 6 months up through Q2 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [26.02$, 43.16$]
- 2026-12-31 to 2027-12-31 estimated range: [25.41$, 42.41$]
Financial Metrics affecting the COVTY estimates:
- Negative: with PPE of -17.7 at the end of fiscal year the price was very high
- Positive: -13.52 < Operating profit margin, % of -3.25
- Positive: 2.37 < Operating cash flow per share per price, % of 3.38
- Positive: 0.59 < Industry operating profit margin (median), % of 1.52
- Positive: Inventory ratio change, % of 0.07 <= 0.41
- Positive: Industry inventory ratio change (median), % of -0.11 <= 0
- Positive: 49.86 < Shareholder equity ratio, % of 51.36 <= 58.56
- Positive: -7.72 < Return on assets ratio (scaled to [-100,100]) of -4.34
- Positive: -18.95 < Investing cash flow per share per price, % of -11.43
- Positive: 2.08 < Industry earnings per price (median), % of 2.85
Short-term COVTY quotes
Long-term COVTY plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | €14,377.00MM | €14,179.00MM | €12,431.21MM |
| Operating Expenses | €14,221.00MM | €14,152.00MM | €12,849.05MM |
| Operating Income | €156.00MM | €27.00MM | €-417.83MM |
| Non-Operating Income | €-83.00MM | €-54.00MM | €-54.75MM |
| Interest Expense | €169.00MM | €159.00MM | €95.09MM |
| R&D Expense | €374.00MM | €392.00MM | €328.50MM |
| Income(Loss) | €73.00MM | €-27.00MM | €-472.58MM |
| Taxes | €275.00MM | €245.00MM | €145.04MM |
| Net Income(Loss)* | €-198.00MM | €-266.00MM | €-618.58MM |
| Stockholders Equity | €6,590.00MM | €6,658.00MM | €6,995.02MM |
| Inventory | €2,455.00MM | €2,847.00MM | €2,501.93MM |
| Assets | €13,637.00MM | €13,631.00MM | €13,619.20MM |
| Operating Cash Flow | €997.00MM | €870.00MM | €379.41MM |
| Capital expenditure | €765.00MM | €781.00MM | €739.61MM |
| Investing Cash Flow | €-925.00MM | €-423.00MM | €-1,282.31MM |
| Financing Cash Flow | €-639.00MM | €-565.00MM | €1,056.59MM |
| Earnings Per Share** | €-0.52 | €-0.70 | €-1.63 |
| Ordinary share to ADR | 1.00x | 1.00x | 1.00x |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.